| pubmed-article:6200845 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6200845 | lifeskim:mentions | umls-concept:C0034107 | lld:lifeskim |
| pubmed-article:6200845 | lifeskim:mentions | umls-concept:C0449864 | lld:lifeskim |
| pubmed-article:6200845 | lifeskim:mentions | umls-concept:C0487742 | lld:lifeskim |
| pubmed-article:6200845 | lifeskim:mentions | umls-concept:C1517942 | lld:lifeskim |
| pubmed-article:6200845 | lifeskim:mentions | umls-concept:C0181586 | lld:lifeskim |
| pubmed-article:6200845 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6200845 | pubmed:dateCreated | 1984-5-24 | lld:pubmed |
| pubmed-article:6200845 | pubmed:abstractText | Postoperative pulse width thresholds were measured at a constant of 5 volts in 140 patients. In 41 patients, transvenous atrial and/or ventricular leads were implanted at a median age of 13 years (3-78 yrs). Myo-epicardial leads were implanted in 99 patients at a median age of 8 3/4 years (1 wk to 76 yrs). The initial rapid rise of threshold was found to persist not longer than to the third follow-up period of 11 days to 5 weeks in all atrial and transvenous ventricular leads; in myo-epicardial ventricular leads it persisted until the period of more than 5 weeks to 6 months. During initial rise, pulse width threshold m + sem did not exceed 0.45 ms. We therefore suggest that a pulse width setting of 0.5 ms at 5 V is a safe setting for this period. In only one patient did a late rise of threshold occur. The comparison of pulse width thresholds of transvenous versus myo-epicardial leads showed lower mean values for transvenous atrial leads in each follow-up period, but the difference was not statistically significant. The pulse width thresholds of transvenous ventricular leads were significantly lower than those of myo-epicardial leads in some follow-up periods. We therefore conclude that transvenous leads have a slight advantage with regard to postoperative pulse width threshold. | lld:pubmed |
| pubmed-article:6200845 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6200845 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6200845 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6200845 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6200845 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6200845 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6200845 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6200845 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:6200845 | pubmed:issn | 0147-8389 | lld:pubmed |
| pubmed-article:6200845 | pubmed:author | pubmed-author:GilletteP CPC | lld:pubmed |
| pubmed-article:6200845 | pubmed:author | pubmed-author:BurnsGG | lld:pubmed |
| pubmed-article:6200845 | pubmed:author | pubmed-author:ShannonCC | lld:pubmed |
| pubmed-article:6200845 | pubmed:author | pubmed-author:HengleinDD | lld:pubmed |
| pubmed-article:6200845 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6200845 | pubmed:volume | 7 | lld:pubmed |
| pubmed-article:6200845 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6200845 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6200845 | pubmed:pagination | 203-14 | lld:pubmed |
| pubmed-article:6200845 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:meshHeading | pubmed-meshheading:6200845-... | lld:pubmed |
| pubmed-article:6200845 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6200845 | pubmed:articleTitle | Long-term follow-up of pulse width threshold of transvenous and myo-epicardial leads. | lld:pubmed |
| pubmed-article:6200845 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6200845 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:6200845 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:6200845 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
